COVID-19 in interstitial lung diseases: are fibrotic ILDs associated with worse outcomes?

M. Serino (Porto, Portugal), B. Martins (Porto, Portugal), M. Martins (Porto, Portugal), C. Valente (Porto, Portugal), I. Carvalho (Porto, Portugal), M. Barbosa (Barreiro-Montijo, Portugal), M. Alves (Lisboa, Portugal), C. Cascais (Aveiro, Portugal), A. Terras Alexandre (Porto, Portugal), N. Melo (Porto, Portugal), P. Caetano Mota (Porto, Portugal), A. Morais (Porto, Portugal), H. Novais-Bastos (Porto, Portugal)

Source: International Congress 2022 – Interstitial lung diseases diagnosis in the COVID-19 era: new tools for new challenges

Session: Interstitial lung diseases diagnosis in the COVID-19 era: new tools for new challenges
Session type: Thematic Poster
Number: 444

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Serino (Porto, Portugal), B. Martins (Porto, Portugal), M. Martins (Porto, Portugal), C. Valente (Porto, Portugal), I. Carvalho (Porto, Portugal), M. Barbosa (Barreiro-Montijo, Portugal), M. Alves (Lisboa, Portugal), C. Cascais (Aveiro, Portugal), A. Terras Alexandre (Porto, Portugal), N. Melo (Porto, Portugal), P. Caetano Mota (Porto, Portugal), A. Morais (Porto, Portugal), H. Novais-Bastos (Porto, Portugal). COVID-19 in interstitial lung diseases: are fibrotic ILDs associated with worse outcomes?. 444

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.